First-in-class treatment to delay onset of type 1 diabetes
First-in-class treatment to delay onset of type 1 diabetes
First-in-class treatment to delay onset of type 1 diabetes
Human medicines European public assessment report (EPAR): Dafiro, amlodipine,valsartan, Date of authorisation: 15/01/2007, Revision: 34, Status: Authorised
Human medicines European public assessment report (EPAR): Copalia, amlodipine,valsartan, Date of authorisation: 15/01/2007, Revision: 33, Status: Authorised
Human medicines European public assessment report (EPAR): Exforge, amlodipine,valsartan, Date of authorisation: 16/01/2007, Revision: 35, Status: Authorised
Risperidone
Search tips
List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)
Human medicines European public assessment report (EPAR): Synjardy, empagliflozin,metformin, Date of authorisation: 27/05/2015, Revision: 32, Status: Authorised
Notification on arrangements for requesting EMA certificates through urgent and standard procedure for December 2025
Human medicines European public assessment report (EPAR): Descovy, emtricitabine,tenofovir alafenamide, Date of authorisation: 21/04/2016, Revision: 21, Status: Authorised